Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

This study has been completed.
Information provided by (Responsible Party):
Bayside Health Identifier:
First received: May 20, 2008
Last updated: April 4, 2012
Last verified: April 2012